Before You Invest In Lifecore Biomedical Inc. (NASDAQ:LFCR), Consider This Metric

In yesterday’s Wall Street session, Lifecore Biomedical Inc. (NASDAQ:LFCR) shares traded at $7.87, down -1.63% from the previous session. As of this writing, 2 analysts cover Lifecore Biomedical Inc. (NASDAQ:LFCR). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $10.00 and a […]